Product Comparison


 
Merck 00006409502
Merck 00006409602
Glaxo Smith Kline 58160082652
Glaxo Smith Kline 58160082552
Merck 00006484141
McKesson # 927964 911400 772679 741665 467749
Description Vaqta® Hepatitis A Vaccine Pediatric / Adolescent, 12 Months Through 18 Years of Age 25 Unit / 0.5 mL Injection Prefilled Syringe 0.5 mL Vaqta® Hepatitis A Vaccine Adult, 19 Years of Age and Older 50 Unit / mL Injection Prefilled Syringe 1 mL HAVRIX® Hepatitis A Vaccine Adult 1440 Unit / mL Injection Prefilled Syringe 1 mL HAVRIX® Hepatitis A Vaccine 12 Months of Age to 18 Years of Age Pediatric 720 Unit / 0.5 mL Injection Prefilled Syringe 0.5 mL Vaqta® Hepatitis A Vaccine Adult, 19 Years of Age and Older 50 Unit / mL Injection Single Dose Vial 1 mL
Manufacturer # 0000640950200006409602581600826525816008255200006484141
Brand Vaqta®Vaqta®HAVRIX®HAVRIX®Vaqta®
Manufacturer MerckMerckGlaxo Smith KlineGlaxo Smith KlineMerck
Invoice VAQTA, SYR PED 25U/0.5ML (10/BX)VAQTA, SYR 50U/ML 1ML (10/CT )HAVRIX, SYR 1440U/ML 1ML PF (10/PK)HAVRIX, SYR W/O NDL 720U/0.5MLPF PED (10/BX)VAQTA, SDV 50U/ML 1ML (10/BX)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Container Type Prefilled SyringePrefilled SyringePrefilled SyringePrefilled SyringeSingle Dose Vial
Country of Origin United StatesUnited StatesUnknownUnknownUnited States
Generic Drug Code 3239398583985349792499622
NDC Number 0000640950200006409602581600826525816008255200006484141
Product Dating McKesson Acceptable Dating: we will ship >= 120 daysMcKesson Acceptable Dating: we will ship >= 120 daysMcKesson Acceptable Dating: we will ship >= 120 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 90 days
Strength 25 Unit / 0.5 mL50 Unit / mL1440 Unit / mL720 Unit / 0.5 mL50 Unit / mL
User Pediatric / Adolescent, 12 Months Through 18 Years of AgeAdult, 19 Years of Age and OlderAdult12 Months of Age to 18 Years of Age PediatricAdult, 19 Years of Age and Older
Volume 0.5 mL1 mL1 mL0.5 mL1 mL
Application Hepatitis A VaccineHepatitis A VaccineHepatitis A VaccineHepatitis A VaccineHepatitis A Vaccine
Dosage Form InjectionInjectionInjectionInjectionInjection
Generic Drug Name Hepatitis A Virus Vaccine / Preservative FreeHepatitis A Virus Vaccine / Preservative FreeHepatitis A Virus Vaccine / Preservative FreeHepatitis A Virus Vaccine / Preservative FreeHepatitis A Virus Vaccine / Preservative Free
Storage Requirements Requires RefrigerationRequires RefrigerationRequires RefrigerationRequires RefrigerationRequires Refrigeration
Type IntramuscularIntramuscularIntramuscularIntramuscularIntramuscular
UNSPSC Code 5120162651201626512016265120162651201626
Features and Benefits
  • VAQTA® [Hepatitis A Vaccine, Inactivated] is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older
  • VAQTA is a sterile suspension for intramuscular injection
  • One milliliter of the vaccine contains approximately 50U of hepatitis A virus antigen, which is purified and formulated without a preservative
  • Each 0.5-mL pediatric dose contains 25U of hepatitis A virus antigen and adsorbed onto approximately 0.225 mg of aluminum provided as amorphous aluminum hydroxy phosphate sulfate, and 35 mcg of sodium borate as a pH stabilizer, in 0.9% sodium chloride
  • 10 Tip-Lok syringes
  • HAVRIX is indicated for active immunization against disease caused by hepatitis A virus (HAV) for persons 12 months of age to 18 years of age pediatric
  • Pre-filled TIP-LOK syringe
  • Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
  • Package of 10 single dose vials
  • Store refrigerated at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit)